In crisis? Call or text 988, the Suicide & Crisis Lifeline, any time, day or night. St. Charles County, Mo.  /  Health Desk Edition
St. Charles Health Desk Local reporting on mental health care
Independent · Nonprofit-model Covering St. Charles, St. Peters,
O'Fallon, Wentzville, Lake Saint Louis
& Cottleville, Missouri

From our survey

Drug-free depression myths St. Charles residents still hear

TMS is not shock therapy and drug-free is not alternative medicine: kitchen-table beliefs about treating depression without pills, checked.

Ask around St. Charles about depression treatment and the same few beliefs come up at kitchen tables, ballfields, and break rooms. Some are harmless. A few keep people stuck. This piece takes on the ones we hear most about treating depression without medication, and checks them against a survey we commissioned this summer.

That survey reached 443 adults across ten Midwest states, Missouri among them. Its numbers are final, and they capture beliefs and preferences, not medical outcomes.

Myth: "Nobody really wants to avoid medication. People just want what works."

Wanting relief and wanting to skip another prescription are not opposites; plenty of people want both. Asked whether a drug-free treatment option mattered, 64 percent of respondents said yes. In our sample that was the majority view, not a fringe one.

The reasons vary. Some people had side effects they could not tolerate. Some are pregnant or hoping to be. Some take other drugs and fear interactions. Some have simply been through several antidepressants and stopped believing the next will differ. None of that is anti-medicine; it is a preference worth hearing.

Myth: "If there were a drug-free option, everyone would know about it."

There is one, and most people do not know it. TMS, short for transcranial magnetic stimulation, has held FDA clearance for years for depression that antidepressants have not relieved, yet in our survey only 25 percent of respondents knew what it was.

The largest group on that question, half of everyone we asked, said TMS was new to them but a drug-free option mattered. That points not to an obscure or unproven treatment but to one that seldom comes up where people learn about care.

Myth: "TMS is just shock therapy with a new name."

It is not. Electroconvulsive therapy is a separate procedure done under general anesthesia that deliberately triggers a brief seizure. It matters for some people with severe depression, but it is a different thing.

TMS uses a coil held to the scalp to send magnetic pulses into a mood-related brain region. You sit awake throughout, nothing puts you under, and most people drive home and resume their day. Scalp soreness and headache are the usual complaints; seizures are uncommon, and screening happens before the first session.

Myth: "Drug-free means alternative medicine."

"Drug-free" sometimes gets lumped in with supplements and wellness products. That is not our meaning. The two drug-free approaches with mainstream standing are psychotherapy, such as cognitive behavioral therapy, and TMS, both delivered by licensed clinicians and often covered by insurance in some form.

Regulatory standing carries weight too. In our survey, 59 percent of respondents counted FDA approval as decisive or weighty in judging a new treatment. For TMS the exact term is "cleared," the route used for many devices, rather than "approved," the term for drugs, but it is still an FDA review.

Myth: "Wanting drug-free means I should stop my antidepressant."

Please do not. Quitting an antidepressant abruptly risks withdrawal and a relapse that can be harsher than before. Many people who start TMS or therapy keep taking their current medication, at least early on, and any change belongs in a talk with the prescriber.

Myth: "Ketamine is the drug-free alternative I keep hearing about."

Ketamine and esketamine are both medications. Esketamine, branded Spravato, has approval from the FDA for treatment-resistant depression, and every dose is observed at a certified healthcare site. Clinics use IV ketamine for depression off label, and ketamine taken at home falls into its own, looser category. Some of these may be worth raising with a clinician, but none is drug-free.

Confusion is common; 73 percent of those we surveyed could not place the name Spravato. When a treatment is unfamiliar it is easy to blur with others, which is why Brain Recovery Centers keeps a clear description of Spravato treatment online.

Myth: "Where I get treated doesn't matter much."

For TMS, location may matter more than almost anything, because a typical course means visits on most weekdays for several weeks. For someone in St. Charles, a clinic in the county and one across St. Louis County are very different commitments once you add I-70 or Page Avenue traffic at the hours you can get free.

Respondents seemed to know it. Choosing their two biggest priorities in a provider, 43 percent picked being near home, topped only by insurance coverage at 85 percent.

Myth: "My doctor would have mentioned it if it were an option."

Maybe, maybe not. Primary care physicians handle an enormous range of problems, and a depression visit often drifts toward adjusting medication. That is not negligence; it is how short appointments go.

The upside: a doctor's word is the one people trust most. Among respondents, 74 percent picked their own doctor's advice as the biggest influence on trying a new treatment, so the most useful move is to ask yourself: "Would TMS or therapy make sense for me, instead of or alongside another medication?"

What to do next in St. Charles County

  • Raise drug-free options directly with your doctor or prescriber, and bring a list of medications you have tried.
  • Phone your insurer about TMS coverage for depression, required records, and in-network providers.
  • Look honestly at your weekly schedule before committing to near-daily treatment, and ask clinics about early or late slots.
  • Consider therapy by video, which can remove the commute entirely.

Sort out which of these fits you together with a clinician who knows you.

If suicidal thoughts are part of what you carry, please tell someone today. Call or text 988 from anywhere in St. Charles County, or anywhere else, at any hour.

Methodology

The publisher commissioned this research and paid its costs. Pollfish ran it on its panel, with fieldwork closing on June 23, 2026. After a consent screener, 443 people finished, every one between 18 and 64 and a resident of the ten sampled Midwest states. Multi-select results are shares of all respondents, and all figures are final.